Propel Bio Management »

Spdr Ser Tr cmn shares owned by Propel Bio Management

Quarter-by-quarter ownership of Spdr Ser Tr cmn (FLRN) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Spdr Ser Tr cmn

Tip: Access up to 7 years of quarterly data

All positions including Spdr Ser Tr cmn held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr Ser Tr cmn by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $284k 9.3k 30.59

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Spdr Ser Tr cmn

Wealthfront Advisers
Wells Fargo & Company
Tiaa Trust, National Association
Jane Street
New York Life Investment Management
Bank Of Montreal
Bank of America Corporation
UBS Group
ValMark Advisers
Facet Wealth
Assetmark
Towercrest Capital Management
McMahon Financial Advisors
Astor Investment Management
Alliance Wealth Management

View all funds holding Spdr Ser Tr cmn